INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BD
Beaven Peter DavidDirector
NEMNEWMONT Corp /DE/
Grant or award
A—
1,092 sh
Sep 2, 2026Sep 3, 2026
Page 404 of 1689
← PrevNext →
traded Sep 2, 2026
+1d
SEC Form 4

Evidence

9
BD
Bersaglini Clark DavidVice President
KMTKENNAMETAL INC
Option exercise
M—
11.6K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
PD
Parrish DeanEVP & Chief Operating Officer
SDSANDRIDGE ENERGY INC
Tax withholding
F$4,153
289 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
AB
Albert BenjaminDirector, CEO
HCATHealth Catalyst, Inc.
Tax withholding
F$547
321 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Option exercise
M—
4,859 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
KF
Keller FrankPres., Checkout Sol. & Paypal
PYPLPayPal Holdings, Inc.
Option exercise
M—
6,903 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
DP
Dalal Jatin PChief Financial Officer
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise
M—
1,529 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
VR
Varrier RajeshPresident Operations CMD India
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Tax withholding
F$14K
210 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Option exercise
M—
5,300 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Option exercise
M—
9,152 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
PD
Paulek Mark DChief Human Resources Officer
KDKyndryl Holdings, Inc.
Tax withholding
F$22K
1,661 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
NJ
Niederpruem Gary JohnDirector, Chief Executive Officer
FPSForgent Power Solutions, Inc.
Grant or award
A—
214.3K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
SJ
Simon JoshDirector, Chief Executive Officer
FNKOFunko, Inc.
Option exercise
M—
250.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
NC
Nueno CarlosPresident, International
TDOCTeladoc Health, Inc.
Option exercise
M—
4,556 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
HT
Hottinger TysonChief Legal Officer
FPSForgent Power Solutions, Inc.
Grant or award
A—
25.7K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
BA
Brown Michael AugustSVP, GC & Corp. Secretary
CWENClearway Energy, Inc.
Grant or award
A—
335 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
BL
Brown Brandon Louis Sr.SVP, Chief Accounting Officer
SDSANDRIDGE ENERGY INC
Tax withholding
F$3,506
244 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
NC
Nueno CarlosPresident, International
TDOCTeladoc Health, Inc.
Option exercise
M—
8,717 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Option exercise
M—
9,152 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
JR
Jani RaviChief Financial Officer
REAXReal REMAX Group Inc.
Disposition to issuer
D—
248 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
DP
Dalal Jatin PChief Financial Officer
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise
M—
1,964 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
PD
Parrish DeanEVP & Chief Operating Officer
SDSANDRIDGE ENERGY INC
Option exercise
M—
1,000 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
XK
Xu KangCHIEF TECHNOLOGY OFFICER
SESSES AI Corp
Tax withholding
F$18K
35.2K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
MC
Malzahn CraigChief Technology Officer
RGNXREGENXBIO Inc.
Tax withholding
F$2,181
234 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
CC
Cornelius CraigDirector, President & CEO
CWENClearway Energy, Inc.
Grant or award
A—
4,277 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
RP
Rackliffe PhilipCEO, AIS
GEHCGE HealthCare Technologies Inc.
Tax withholding
F$24K
340 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
KF
Keller FrankPres., Checkout Sol. & Paypal
PYPLPayPal Holdings, Inc.
Option exercise
M—
3,418 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$449K
1,400 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$965K
22.8K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$406K
4,999 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$273K
2,600 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$649K
24.2K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Tax withholding
F$259K
9,435 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Tax withholding
F$60K
2,563 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
858 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

7
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Option exercise · 10b5-1 plan
M—
8,717 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
SP
Smith Kevin P.EVP, Bus Dev, GC & Sec
INGNInogen Inc
Tax withholding · 10b5-1 plan
F$46K
8,671 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
1,833 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$134K
7,500 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$207K
9,375 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence